PTC Inc. (PTC)
PTC Therapeutics Targets Fabry Gene Therapy in $111M Bankruptcy Auction Deal
PTC Therapeutics NASDAQ: PTCT plans to acquire the ST-920 Fabry disease gene therapy asset through a competitive bankruptcy auction, positioning the company to add a potential one-time treatment to its rare disease portfolio while using its existing global commercial and regulatory infrastructure.
PTC Rides AI, Cloud and Product Data Trends Across Industrial Markets
PTC is turning governed product data, cloud collaboration and focused AI pilots into broader industrial software and service opportunities.
PTC's AI-Led Lifecycle Strategy Reshapes Its Long-Term Growth Outlook
PTC's tighter focus on product data, lifecycle software and AI sharpens its growth story, but fourth-quarter ARR conversion remains the key execution test.
Is PTC Stock Attractive After Its Sharp Pullback and Mixed Earnings?
PTC's valuation reset and buybacks improve its risk-reward profile, but weak revenue, margin pressure and a demanding fourth quarter keep execution in focus.
PTC Q3 Earnings & Sales Lag, ARR View Raised on AI Momentum & Buybacks
PTC lifted its fiscal 2026 revenue, EPS and ARR outlook, despite quarterly revenue and earnings missing expectations.
PTC Inc. (PTC) Q3 2026 Earnings Call Transcript
PTC Inc. (PTC) Q3 2026 Earnings Call Transcript
PTC Q3 Earnings Call Highlights
PTC NASDAQ: PTC reported third-quarter fiscal 2026 results that exceeded the high end of its guidance for constant-currency annual recurring revenue, as the engineering software company cited stronger demand capture, improved retention and progress in its go-to-market transformation.
PTC Inc. (PTC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for PTC Inc. (PTC) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
PTC Inc. (PTC) Q3 Earnings and Revenues Miss Estimates
PTC Inc. (PTC) came out with quarterly earnings of $1.58 per share, missing the Zacks Consensus Estimate of $1.6 per share. This compares to earnings of $1.64 per share a year ago.
PTC Gears Up to Report Q3 Earnings: What's in the Offing?
PTC heads into fiscal Q3 2026 earnings with recurring revenue strength, AI product launches and a stronger pipeline, but forex headwinds could weigh on reported growth.
PTC Inc. (PTC) Discusses Unlocking Business Value and Growth Opportunities in Modern ALM Prepared Remarks Transcript
PTC Inc. (PTC) Discusses Unlocking Business Value and Growth Opportunities in Modern ALM Prepared Remarks Transcript
PTC Targets ALM Growth as Codebeamer Gains Traction in Software-Defined Products
PTC NASDAQ: PTC used a partner webinar to outline what executives described as a significant growth opportunity in application lifecycle management, or ALM, driven by increasingly software-defined products, regulatory demands and the need for large enterprises to modernize engineering processes.
